4D Molecular Therapeutics FDMT
NASDAQ FDMT
$13.84 -0.47 (-3.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

4D Molecular Therapeutics (FDMT) Depreciation & Amortization (CF) (2020 - 2026)

Updated

4D Molecular Therapeutics' Depreciation & Amortization (CF) was $1.28 million in Q2 2026, up 9.8% from $1.17 million a year earlier and up 0.9% from the prior quarter.

Analysis

4D Molecular Therapeutics (FDMT) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, 4D Molecular Therapeutics' Depreciation & Amortization (CF) was $5.03 million through Jun 30, 2026, up 11.6% year-over-year; for FY2025, it came in at $4.69 million, up 0.9% from FY2024.

  • Depreciation & Amortization (CF) has now increased for six consecutive years, with a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $4.65 million in FY2024 (+10.7%), $4.2 million in FY2023 (+74.9%), $2.4 million in FY2022 (+57.8%) and $1.52 million in FY2021 (+5.5%).
  • The Q2 2026 figure marks the highest quarterly Depreciation & Amortization (CF) in data going back to Q1 2020.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for four straight quarters, with growth averaging 6.7% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q4 2022 (growth of 160.0%); the worst was Q1 2025 (a decline of 10.4%).
  • Per Business Quant data, FDMT's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $1.27 million (Q1 2026), $1.22 million (Q4 2025) and $1.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 4D Molecular Therapeutics 1.01 Bn -454.35 Mn - 1.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.28 Mn
Mar 31, 2026 1.27 Mn
Dec 31, 2025 1.22 Mn
Sep 30, 2025 1.26 Mn
Jun 30, 2025 1.17 Mn
Mar 31, 2025 1.05 Mn
Dec 31, 2024 1.10 Mn
Sep 30, 2024 1.19 Mn
Jun 30, 2024 1.19 Mn
Mar 31, 2024 1.17 Mn
Dec 31, 2023 1.10 Mn
Sep 30, 2023 994,000.00
Jun 30, 2023 1.08 Mn
Mar 31, 2023 1.03 Mn
Dec 31, 2022 1.01 Mn
Sep 30, 2022 517,000.00
Jun 30, 2022 466,000.00
Mar 31, 2022 406,000.00
Dec 31, 2021 390,000.00
Sep 30, 2021 380,000.00
API Access

4D Molecular Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=FDMT&period=max&api_key=YOUR_API_KEY